Trump ordered his administration on Thursday to consider imposing reciprocal tariffs on a country-by-country basis ...

EU exports to the US reached $605.8 billion in 2024, according to the US Census Bureau. Pharmaceutical companies are particularly vulnerable, according to BI strategists Laurent Douillet and Kaidi ...

As worries about U.S. tariffs eased following U.S. President Donald Trump's decision to delay levies on Canada and Mexico, investors ...

Official Action Indicated (OAI). Not many investors may have heard of this. But they would surely have felt its impact. For, the moment OAI is triggered, the stock price slips sharply. OAI is nothing ...

European stocks trimmed earlier declines after Mexican President Claudia Sheinbaum said tariffs imposed by the US would be delayed for one month after a conversation with Donald Trump.

The deal will diversify the French beauty giant’s funding sources at a time when the industry is undergoing a slowdown.

Trump announced levies on Canada, Mexico and China at the weekend, and promised to make similar moves against the European Union. He confirmed the delay to Mexico’s tariffs in a post on Truth ...

L’Oréal remains an important shareholder of Sanofi and is fully supportive of the company’s value creation strategy,” said L’Oréal. “The transaction will optimize L ...

PARIS – L’Oréal has agreed to sell about 29.6 million Sanofi shares to Sanofi for approximately 3 billion euros. The transaction is to be priced at 101.50 euros per share, the French beauty ...

Sanofi’s Sarclisa has received approval in more than 50 nations for multiple indications. Credit: rafaelnlins/Shutterstock. Sanofi has received China’s National ...